Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « therapies »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
therapeutics < therapies < therapy  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000027 (2020) Berthold Bein ; Martin Bachmann ; Susanne Huggett ; Petra Wegermann[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].
000040 (2020) X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine][From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].
000049 (2020) B. El Boussadani [Maroc] ; C. Benajiba [Maroc] ; A. Aajal [Maroc] ; A. Ait Brik [Maroc] ; O. Ammour [Maroc] ; J. El Hangouch [Maroc] ; O. Oussama [Maroc] ; B. Oussama [Maroc] ; N. Tahiri [Maroc] ; Z. Raissuni [Maroc][COVID-19 pandemia: Impact on the cariovascular system. Data of 1st April 2020].
000095 (2020) Mingxiang Ye [République populaire de Chine] ; Dian Fu [République populaire de Chine] ; Yi Ren [République populaire de Chine] ; Faxiang Wang [République populaire de Chine] ; Dong Wang [République populaire de Chine] ; Fang Zhang [République populaire de Chine] ; Xinyi Xia [République populaire de Chine] ; Tangfeng Lv [République populaire de Chine]Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
000101 (2020) Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin ChenTraditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
000125 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000167 (2020) Leon Caly [Australie] ; Julian D. Druce [Australie] ; Mike G. Catton [Australie] ; David A. Jans [Australie] ; Kylie M. Wagstaff [Australie]The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
000186 (2020) Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis]Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.
000241 (2020) Indwiani AstutiSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
000286 (2020) Michele Costanzo ; Maria Anna Rachele De Giglio ; Giovanni Nicola RovielloSARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.
000300 (2020) Ashley Barlow [États-Unis] ; Kaitlin M. Landolf [États-Unis] ; Brooke Barlow [États-Unis] ; Siu Yan Amy Yeung [États-Unis] ; Jason J. Heavner [États-Unis] ; Cassidy W. Claassen [Zambie] ; Mojdeh S. Heavner [États-Unis]Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
000331 (2020) Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde]Recent discovery and development of inhibitors targeting coronaviruses
000385 (2020) Giuseppe Rombolà [Italie] ; Marco Hedemperger [Italie] ; Luciano Pedrini [Italie] ; Marco Farina [Italie] ; Filippo Aucella [Italie] ; Piergiorgio Messa [Italie] ; Giuliano Brunori [Italie]Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy
000387 (2020) Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran]Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.
000454 (2020) Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France]New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
000474 (2020) Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie]Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
000491 (2020) Pietro H. Guzzi [Italie] ; Daniele Mercatelli [Italie] ; Carmine Ceraolo [Italie] ; Federico M. Giorgi [Italie]Master Regulator Analysis of the SARS-CoV-2/Human Interactome.
000546 (2020) Gionata Fiorino [Italie] ; Mariangela Allocca [Italie] ; Federica Furfaro [Italie] ; Daniela Gilardi [Italie] ; Alessandra Zilli [Italie] ; Simona Radice [Italie] ; Antonino Spinelli [Italie] ; Silvio Danese [Italie]Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.
000586 (2020) P. Conti [Italie] ; C E Gallenga [Italie] ; G. Tetè [Italie] ; Al Caraffa [Italie] ; G. Ronconi [Italie] ; A. Younes [Italie] ; E. Toniato [Italie] ; R. Ross [États-Unis] ; S K Kritas [Grèce]How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
000761 (2020) Stephan Ludwig [Allemagne] ; Alexander Zarbock [Allemagne]Coronaviruses and SARS-CoV-2: A Brief Overview.
000879 (2020) Bingwen Liu [République populaire de Chine] ; Min Li [République populaire de Chine] ; Zhiguang Zhou [République populaire de Chine] ; Xuan Guan [États-Unis] ; Yufei Xiang [République populaire de Chine]Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "therapies" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "therapies" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    therapies
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021